(2E)-2,4-Dimethylpent-2-enoic acid
| Common Name: |
(2E)-2,4-Dimethylpent-2-enoic acid |
| IUPAC Name: |
(E)-2,4-dimethylpent-2-enoic acid |
| Molecular Formula: |
C15H32O6 |
| SMILES: |
CC(C)C=C(C)C(=O)O |
| Inchi: |
1S/C7H12O2/c1-5(2)4-6(3)7(8)9/h4-5H,1-3H3,(H,8,9)/b6-4+ |
| Inchi Key: |
DMHLGGQHOSTMJG-GQCTYLIASA-N |
| Cas No: |
66634-97-7 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
1 |
| Egan Violations |
0 |
| Muegge Violations |
0 |
| Name |
Value |
| Molecular Weight (g/mol) |
308.41 |
| Mass (g/mol) |
128.084 |
| Molar Refractivity |
80.73 |
| Net Charge |
-1 |
| HBD |
|
| HBA |
6 |
| Rt Bonds |
14 |
| Rings |
|
| TPSA |
55.38 |
| Hetero Atoms |
2 |
| Heavy Atoms |
21 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
133.00 to 134.00 @ 15.00 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
0.052 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
1.00 |
| LogP |
1.673 |
| iLOGP |
4.30 |
| XLOGP3 |
2.10 |
| WLOGP |
2.55 |
| MLOGP |
1.12 |
| ESOL Log S |
-2.15 |
| ESOL Solubility (mg/ml) |
2.18 |
| ESOL Solubility (mol/l) |
0.007 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-2.89 |
| Ali Solubility (mg/ml) |
0.39 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.85 |
| Silicos-IT Solubility (mg/ml) |
0.44 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
1 |
| Log Kp (cm/s) |
-6.69 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.537 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.673 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
